NEW YORK (GenomeWeb News) – Life Technologies said today that it has agreed to buy the genomics technologies firm BioTrove for an undisclosed sum.

The definitive merger agreement will give Life Technologies a high-throughput gene expression and genotyping system, the OpenArray, that will complement the company’s next-generation and PCR portfolio by enabling researchers to validate samples against large target panels, Life Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.